Redefining Chemoresistance: Natural Bioactives as Molecular Modulators at the Cancer-Tumor Microenvironment Interface

Claudia Reytor-González1, Emilia Jiménez-Flores1, Natalí González2

  • 1Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito 170527, Ecuador.

Insights

Natural compounds show promise in overcoming cancer therapeutic resistance by modulating cancer cell behavior and the tumor microenvironment. Further research is needed to integrate these bioactives into clinical practice for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Therapeutic resistance is a major challenge in cancer treatment, leading to poor patient outcomes.
  • Natural bioactive compounds offer potential as adjuncts to overcome resistance by targeting multiple pathways.
  • Understanding their mechanisms and interactions within the tumor microenvironment is crucial.

Purpose of the Study:

  • To review the current evidence on natural compounds' role in influencing cancer cell behavior and the tumor microenvironment.
  • To provide a structured overview of natural compounds, organized by chemical families, for enhancing chemotherapy efficacy.
  • To highlight strategies for improving the clinical applicability of natural compounds in cancer therapy.

Main Methods:

  • Systematic review of preclinical and clinical studies on natural compounds and cancer resistance.
  • Categorization of natural compounds into distinct chemical families.
  • Analysis of their impact on cancer cell signaling, drug metabolism, and tumor microenvironment modulation.
  • Exploration of combination therapies and novel drug delivery systems.

Main Results:

  • Natural compounds modulate key cellular processes implicated in therapeutic resistance.
  • Evidence suggests potential for enhancing standard chemotherapy efficacy and overcoming resistance mechanisms.
  • Specific chemical families show promise in targeting cancer cell behavior and tumor microenvironment interactions.
  • Combination therapies and advanced delivery systems are emerging strategies for clinical translation.

Conclusions:

  • Natural bioactive compounds are relevant adjuncts for modern cancer therapy, offering multifaceted mechanisms to combat resistance.
  • Translational research is essential to bridge promising preclinical findings with effective clinical implementation.
  • Further investigation into combination strategies and delivery systems will enhance the therapeutic potential of natural compounds in oncology.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K